Company Search:
Advanced Search
Sponsored Links
Sunesis Pharmaceuticals, Inc. Company Snapshot
Sunesis Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sunesis Pharmaceuticals with three other companies in this sector in the United States: Nutriband Inc (2018 sales of $245,285.00 of which 80% was Services), Scynexis Inc ($257,000.00 ), and Cellular Biomedicine Group Inc ($224,403.00 of which 100% was Biomedicine).

Sales Analysis. Sunesis Pharmaceuticals reported sales of $237,000.00 for the year ending December of 2018. This represents a sharp decrease of 64.6% versus 2017, when the company's sales were $669,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sunesis Pharmaceuticals, Inc.
  Stock Performance Chart for Sunesis Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/21/2020): .87
(Figures in U.S. Dollars)
1 Week 4.1%   13 Weeks 61.7%  
4 Weeks 95.4%   52 Weeks 63.4%  
Sunesis Pharmaceuticals, Inc. Key Data:
  Ticker: SNSS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 237,000
(Year Ending Jan 2019).
Employees: 29
  Currency: U.S. Dollars Market Cap: 97,338,208
  Fiscal Yr Ends: December Shares Outstanding: 111,320,000
  Share Type: Common Closely Held Shares: 173,936
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.